Total Payments
$3,680
2024 Payments
$176.75
Companies
25
Transactions
203
Medicare Patients
3,984
Medicare Billing
$423,275
Payment Breakdown by Category
Food & Beverage$3,646 (99.1%)
Education$33.95 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,646 | 199 | 99.1% |
| Education | $33.95 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $778.25 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $387.20 | 24 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $352.45 | 21 | $0 (2019) |
| Novo Nordisk Inc | $303.67 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $223.84 | 8 | $0 (2020) |
| Lilly USA, LLC | $182.90 | 9 | $0 (2022) |
| Allergan, Inc. | $176.77 | 12 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $173.19 | 9 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $146.34 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $145.41 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $176.75 | 9 | Novartis Pharmaceuticals Corporation ($40.44) |
| 2023 | $115.11 | 5 | PFIZER INC. ($53.04) |
| 2022 | $76.25 | 4 | Lilly USA, LLC ($40.27) |
| 2021 | $63.03 | 3 | Lilly USA, LLC ($63.03) |
| 2020 | $123.85 | 9 | Janssen Pharmaceuticals, Inc ($44.00) |
| 2019 | $779.57 | 51 | PFIZER INC. ($151.01) |
| 2018 | $1,020 | 52 | PFIZER INC. ($224.79) |
| 2017 | $1,325 | 70 | PFIZER INC. ($304.88) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROLOGY | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Respiratory | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Inflammation | ||||||
| 03/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Central Nervous System | ||||||
| 07/20/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: INSOMNIA | ||||||
| 06/29/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: INSOMNIA | ||||||
| 06/22/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $53.04 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Obesity | ||||||
| 04/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Diabetes | ||||||
| 09/08/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Obesity | ||||||
| 05/12/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Neuroscience | ||||||
| 03/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/17/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Neuroscience | ||||||
| 12/09/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Neuroscience | ||||||
| 10/07/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Neuroscience | ||||||
| 09/23/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Neuroscience | ||||||
| 03/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/24/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/06/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 953 | 1,202 | $276,195 | $116,335 |
| 2022 | 12 | 955 | 1,182 | $260,171 | $106,073 |
| 2021 | 14 | 865 | 1,046 | $218,184 | $93,748 |
| 2020 | 20 | 1,211 | 1,479 | $323,102 | $107,120 |
Total Patients
3,984
Total Services
4,909
Medicare Billing
$423,275
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 337 | $91,522 | $31,135 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 202 | 202 | $55,934 | $27,258 | 48.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 186 | 188 | $33,268 | $15,559 | 46.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 93 | 101 | $22,725 | $10,499 | 46.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 47 | 51 | $15,300 | $7,514 | 49.1% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 13 | 35 | $12,870 | $5,085 | 39.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 51 | 80 | $11,410 | $4,435 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 60 | $11,491 | $3,592 | 31.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 48 | 48 | $6,720 | $3,453 | 51.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 29 | 38 | $7,290 | $3,183 | 43.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $5,704 | $3,081 | 54.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 49 | 49 | $1,960 | $1,542 | 78.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 180 | 180 | $49,842 | $24,430 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 257 | $69,796 | $23,670 | 33.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 172 | 172 | $30,437 | $14,415 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 168 | $32,175 | $10,620 | 33.0% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 70 | 75 | $16,875 | $7,530 | 44.6% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 46 | 47 | $14,100 | $6,291 | 44.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 43 | 87 | $12,425 | $4,323 | 34.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 54 | 54 | $7,543 | $3,698 | 49.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 16 | $7,020 | $3,692 | 52.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $10,872 | $3,063 | 28.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 26 | 35 | $6,685 | $2,493 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 60 | 60 | $2,400 | $1,849 | 77.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 144 | 144 | $41,463 | $20,120 | 48.5% |
About Dr. Eric Weber, MD
Dr. Eric Weber, MD is a Internal Medicine healthcare provider based in West Yarmouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376572966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Weber, MD has received a total of $3,680 in payments from pharmaceutical and medical device companies, with $176.75 received in 2024. These payments were reported across 203 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,646).
As a Medicare-enrolled provider, Weber has provided services to 3,984 Medicare beneficiaries, totaling 4,909 services with total Medicare billing of $423,275. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location West Yarmouth, MA
- Active Since 07/03/2006
- Last Updated 04/18/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376572966
Products in Payments
- CHANTIX (Drug) $262.92
- ELIQUIS (Drug) $260.15
- ANORO (Drug) $229.11
- XARELTO (Drug) $217.82
- JARDIANCE (Drug) $150.06
- EXCLUDER AAA Endoprosthesis (Device) $146.34
- SYMBICORT (Drug) $121.92
- STIOLTO RESPIMAT (Drug) $121.38
- Trintellix (Drug) $113.99
- Tresiba (Drug) $110.55
- EMGALITY (Drug) $103.30
- JANUVIA (Drug) $92.25
- ENTRESTO (Drug) $90.85
- Victoza (Drug) $90.49
- VIAGRA (Drug) $89.82
- Peripheral Orbital Atherectomy System (Device) $84.14
- TRULICITY (Drug) $79.60
- VIBERZI (Drug) $77.90
- PAXLOVID (Drug) $70.42
- Prolia (Biological) $58.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.